Contents
Recent Patents on CNS Drug Discovery (Discontinued), Volume 1 - Number 1
Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
, 1(1): 1 - 27Shigeyuki Chaki, Taketoshi Okubo and Yoshinori Sekiguchi
DOI: 10.2174/157488906775245318
Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
, 1(1): 29 - 41Christiaan B. Brink, Brian H. Harvey and Linda Brand
DOI: 10.2174/157488906775245327
The Quest to Repair the Damaged Spinal Cord
, 1(1): 55 - 63Maria T. Moreno-Flores and Jesus Avila
DOI: 10.2174/157488906775245264
TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
, 1(1): 65 - 76Louise A. Roberts and Mark Connor
DOI: 10.2174/157488906775245309
Voltage-Gated Sodium Channel Blockers as Immunomodulators
, 1(1): 83 - 91Francesco Roselli, Paolo Livrea and Emilio Jirillo
DOI: 10.2174/157488906775245255
The Astrocytic GABAA/Benzodiazepine-Like Receptor: The Joker Receptor for Benzodiazepine-Mimetic Drugs?
, 1(1): 93 - 103Leif Hertz, Zhong Zhao and Ye Chen
DOI: 10.2174/157488906775245273
Galanthamine, a Natural Product for the Treatment of Alzheimers Disease
, 1(1): 105 - 111Luis Marco and Maria d. C. Carreiras
DOI: 10.2174/157488906775245246
An Update on GABA Analogs for CNS Drug Discovery
, 1(1): 113 - 118Perumal Yogeeswari, Jegadeesan V. Ragavendran and Dharmarajan Sriram
DOI: 10.2174/157488906775245291
Therapeutic Perspectives in Alzheimers Disease
, 1(1): 119 - 127Jakob-A. Tschape and Tobias Hartmann
DOI: 10.2174/157488906775245354
Webmaster Contact: info@benthamscience.org